Publications

Acen, E. L., Biraro, I. A., Bbuye, M., Kateete, D. P., Joloba, M. L., & Worodria, W. (2022). Hypovitaminosis D among newly diagnosed pulm7onary TB patients and their household contacts in Uganda. Scientific Reports, 12(1), 1–8. https://doi.org/10.1038/s41598-022-09375-7

Acen, E. L., Kateete, D. P., Worodria, W., Olum, R., Joloba, M. L., Bbuye, M., & Biraro, I. A. (2022). Evaluation of circulating serum cathelicidin levels as a potential biomarker to discriminate between active and latent tuberculosis in Uganda. Plos One, 17(8), e0272788. https://doi.org/10.1371/journal.pone.0272788

Bulage, L., Imoko, J., Joloba, M. L., Kirenga, B. J., Lo, T., Byabajungu, H., … Bloss, E. (2015). Quality of Sputum Specimen Samples Submitted for Culture and Drug Susceptibility Testing at the National Tuberculosis Reference Laboratory-Uganda, July-October 2013. Journal of Tuberculosis Research, 03(03), 97–106. https://doi.org/10.4236/jtr.2015.33015

Kabahita, J. M., Kabugo, J., Joloba, M. L., Kakooza, F., Adam, I., Guido, O., … Mboowa, G. (2022). First report of whole-genome analysis of an extensively drug-resistant Mycobacterium tuberculosis clinical isolate with bedaquiline, linezolid and clofazimine resistance from Uganda. Antimicrobial Resistance and Infection Control, 11(1), 1–8. https://doi.org/10.1186/s13756-022-01101-2

Kamulegeya, R., Kateete, D. P., Bagaya, B. S., Nasinghe, E., Muttamba, W., Nsubuga, G., … Joloba, M. L. (2022). Biobanking: Strengthening Uganda’s Rapid Response to COVID-19 and Other Epidemics. Biopreservation and Biobanking, 20(3), 238–243. https://doi.org/10.1089/bio.2021.0022

Katongole, P., Sande, O. J., Nabweyambo, S., Joloba, M., Kajumbula, H., Kalungi, S., … Niyonzima, N. (2022). IL-6 and IL-8 cytokines are associated with elevated prostate-specific antigen levels among patients with adenocarcinoma of the prostate at the Uganda Cancer Institute. Future Oncology, 18(6), 661–667. https://doi.org/10.2217/fon-2021-0683

Katongole, P., Sande, O. J., Reynolds, S. J., Joloba, M., Kajumbula, H., Kalungi, S., … Niyonzima, N. (2022). Soluble Programmed Death-Ligand 1 (sPD-L1) is Elevated in Aggressive Prostate Cancer Disease Among African Men. Oncology and Therapy, 10(1), 185–193. https://doi.org/10.1007/s40487-022-00184-6

Masiga, F., Kigozi, E., Najjuka, C. F., Kajumbula, H., & Kateete, D. P. (2022). Diarrhoeagenic Escherichia coli isolated from children with acute diarrhoea at Rakai hospital, Southern Uganda. African Health Sciences, 22(1), 581–588. https://doi.org/10.4314/ahs.v22i1.67

Mbiine, R., Wayengera, M., Ocan, M., Kiwanuka, N., Munabi, I., Muwonge, H., … Joloba, M. (2022). Adipose-derived stromal vascular fraction ( SVF ) in scar treatment : a systematic review protocol, 11(4), 56–63. https://pubmed.ncbi.nlm.nih.gov/36189175

Mujuni, D., Kasemire, D. L., Joloba, M. L., Ibanda, I., Kabugo, J., Nsawotebba, A., … Ssengooba, W. (2022). Molecular characterisation of second-line drug resistance among drug resistant tuberculosis patients tested in Uganda: a two and a half-year’s review. BMC Infectious Diseases, 22(1), 1–10. https:// doi.org/10.1186/s12879-022-07339-w

Musisi, E., Sessolo, A., Kaswabuli, S., Joloba, M. L., Zawedde, J., Byanyima, P., … Sabiiti, W. (2022). High Mycobacterium tuberculosis Bacillary Loads Detected by Tuberculosis Molecular Bacterial Load Assay in Patient Stool: a Potential Alternative for Nonsputum Diagnosis and Treatment Response Monitoring of Tuberculosis. Microbiology Spectrum, 10(1), 1–12. https://doi.org/10.1128/spectrum.02100-21

Mutayoba, B. K., Michael Hoelscher, Heinrich, N., Joloba, M. L., Lyamuya, E., Kilale, A. M., … Pletschette, M. (2022). Phylogenetic lineages of tuberculosis isolates and their association with patient demographics in Tanzania. BMC Genomics, 23(1), 1–9. https://doi.org/10.1186/s12864-022-08791-3

Muwonge, H., Kasujja, H., Niyonzima, N., Kateete, D. P., Atugonza, C., Kasolo, J., … Bwanga, F. (2022). Unique circulating microRNA profiles in epidemic Kaposi’s sarcoma. Non-Coding RNA Research, 7(2), 114–122. https://doi.org/10.1016/j.ncrna.2022.02.002

Nabakooza, G., Pastusiak, A., Kateete, D. P., Lutwama, J. J., Kitayimbwa, J. M., & Frost, S. D. W. (2022). Whole-genome analysis to determine the rate and patterns of intra-subtype reassortment among influenza type-A viruses in Africa. Virus Evolution, 8(1), 1–15. https://doi.org/10.1093/ve/veac005

Najjuka, S. M., Ngabirano, T. D., Balizzakiwa, T., Nabadda, R., Kaggwa, M. M., Kateete, D. P., … Kiguli, S. (2022). Health Care Workers’ Perceived Self-Efficacy to Manage COVID-19 Patients in Central Uganda: A Cross-Sectional Study. Risk Management and Healthcare Policy, 15(June), 1253–1270. https://doi.org/10.2147/RMHP.S356410

Nantale, M., Joloba, M. L., Diana, B., Talemwa, N., Tania, R., Achilles, K., … Sara, A. (2022). Multicomponent Strategy with Decentralized Molecular Testing for Tuberculosis, 385(26), 2441–2450. https://doi. org/10.1056/NEJMoa2105470.Multicomponent

Perier, C., Nasinghe, E., Joloba, M. L., Charles, I., Ssetaba, L. J., Ahyong, V., … Schaletzky, J. (2022). Workshop-based learning and networking: a scalable model for research capacity strengthening in low-and middle-income countries. Global Health Action, 15(1). https://doi.org/10.1080/16549716.2022.206 2175

Pitzer, A., Elijovich, F., Laffer, C. L., Ertuglu, L. A., Sahinoz, M., Saleem, M., … Kirabo, A. (2022). DC ENaC-Dependent Inflammasome Activation Contributes to Salt-Sensitive Hypertension. Circulation Research, 131(4), 328–344. https://doi.org/10.1161/CIRCRESAHA.122.320818

Wayengera, M., Babirye, P., Musubika, C., Kirimunda, S., & L. Joloba, M. (2019). Cloning, Expression and Purification of Recombinant Forms of Full Length and Extracellular Domain EBOV Glycoprotein within Mammalian Cell-Lines. Journal of Antivirals & Antiretrovirals, 11(3), 1–8. https://doi.org/10.35248/1948-5964.19.11.187

Matovu B, Takuwa M, Mpaata CN, Denison F, Kiwanuka N, Lewis S, Norrie J, Ononge S, Muhimbise O, Tuck S, Etuket MD. Review of investigational medical devices’ clinical trials and regulations in Africa as a benchmark for new innovations. Frontiers in Medical Technology. 2022;4.

Takuwa M, Mbabazi SE, Tusabe M, Mulindwa B, Makobore PN, Mulerwa M, Kansiime EC, Birungi DM, Reboud J, Cooper J, Robert S. Mobile health access and utilisation in Uganda: knowledge, attitudes and perceptions of health and veterinary workers. Telemedicine and e-Health. 2022.

Morgado Ramirez DZ, Nakandi B, Ssekitoleko R, Ackers L, Mwaka E, Kenney L, Holloway C, Donovan-Hall M. The lived experience of people with upper limb absence living in Uganda: A qualitative study. African Journal of Disability. 2022 May 20;11:890.

Kiwumulo HF, Muwonge H, Ibingira C, Lubwama M, Kirabira JB, Ssekitoleko RT. Green synthesis and characterization of iron-oxide nanoparticles using Moringa oleifera: a potential protocol for use in low and middle income countries. BMC Research Notes. 2022 Dec;15(1):1-8.

Owino SC, Etuket MD, Muhimbise O, Kiwanuka M, Arinda BN, Mukiibi D, Kiwanuka N, Ssekitoleko RT, Ononge S. The Usability, Acceptability, and Performance of the Maternal PPH Wrap Device in Controlling Postpartum Hemorrhage: A Pilot Study at Kawempe National Referral Hospital, Uganda. IEEE Journal of Translational Engineering in Health and Medicine. 2022 Aug 16;10:1-7.

Mujuni, D., Kasemire, D. L., Ibanda, I., Kabugo, J., Nsawotebba, A., Phelan, J. E., … & Ssengooba, W. (2022). Molecular characterisation of second-line drug resistance among drug resistant tuberculosis patients tested in Uganda: a two and a half-year’s review. BMC Infectious Diseases, 22(1), 1-10.

Acen, E. L., Kateete, D. P., Worodria, W., Olum, R., Joloba, M. L., Bbuye, M., & Biraro, I. A. (2022). Evaluation of circulating serum cathelicidin levels as a potential biomarker to discriminate between active and latent tuberculosis in Uganda. PloS one, 17(8), e0272788.

Acen, E. L., Biraro, I. A., Bbuye, M., Kateete, D. P., Joloba, M. L., & Worodria, W. (2022). Hypovitaminosis D among newly diagnosed pulmonary TB patients and their household contacts in Uganda. Scientific reports, 12(1), 5296.

Kabahita, J. M., Kabugo, J., Kakooza, F., Adam, I., Guido, O., Byabajungu, H., … & Mboowa, G. (2022). First report of whole-genome analysis of an extensively drug-resistant Mycobacterium tuberculosis clinical isolate with bedaquiline, linezolid and clofazimine resistance from Uganda. Antimicrobial Resistance & Infection Control, 11(1), 68.

Jjingo, D., Mboowa, G., Sserwadda, I., Kakaire, R., Kiberu, D., Amujal, M., … & Whalen, C. C. (2022).

Bioinformatics mentorship in a resource limited setting. Briefings in Bioinformatics, 23(1), bbab399.

Mutayoba, B. K., Hoelscher, M., Heinrich, N., Joloba, M. L., Lyamuya, E., Kilale, A. M., … & Pletschette, M. (2022). Phylogenetic lineages of tuberculosis isolates and their association with patient demographics in Tanzania. BMC genomics, 23(1), 1-9.

Musisi, E., Sessolo, A., Kaswabuli, S., Zawedde, J., Byanyima, P., Kasinga, S., … & Sabiiti, W. (2022). High mycobacterium tuberculosis bacillary loads detected by tuberculosis molecular bacterial load assay in patient stool: a potential alternative for nonsputum diagnosis and treatment response monitoring of tuberculosis. Microbiology spectrum, 10(1), e02100-21.

Bongomin, F., Kwizera, R., Mande, E., Aloyo, S. M., Achan, B., Namusobya, M., … & Kirenga, B. J. (2022). Aspergillus-specific IgM/IgG antibody serostatus of patients hospitalized with moderate-critical COVID-19 in Uganda. African Health Sciences, 22(3), 506-511.

Thompson, R. R., Nalugwa, T., Oyuku, D., Tucker, A., Nantale, M., Nakaweesa, A., … & Sohn, H. (2023). Multicomponent strategy with decentralised molecular testing for tuberculosis in Uganda: a cost and cost-effectiveness analysis. The Lancet Global Health, 11(2), e278-e286.

Kateete, D. P., Kimani, C. N., Katabazi, F. A., Okeng, A., Okee, M. S., Nanteza, A., … & Najjuka, F. C. (2010). Identification of Staphylococcus aureus: DNase and Mannitol salt agar improve the efficiency of the tube coagulase test. Annals of clinical microbiology and antimicrobials, 9(1), 1-7.

Kirenga, B., Muttamba, W., Kayongo, A., Nsereko, C., Siddharthan, T., Lusiba, J., … & Bazeyo, W. (2020). Characteristics and outcomes of admitted patients infected with SARS-CoV-2 in Uganda. BMJ open respiratory research, 7(1), e000646.

Kateete, D. P., Nakanjako, R., Okee, M., Joloba, M. L., & Najjuka, C. F. (2017). Genotypic diversity among multidrug resistant Pseudomonas aeruginosa and Acinetobacter species at Mulago Hospital in Kampala, Uganda. BMC research notes, 10, 1-10.

Stein, C. M., Zalwango, S., Malone, L. L., Thiel, B., Mupere, E., Nsereko, M., … & Mayanja-Kizza, H. (2018). Resistance and susceptibility to Mycobacterium tuberculosis infection and disease in tuberculosis households in Kampala, Uganda. American journal of epidemiology, 187(7), 1477-1489.

Traore, H., Ogwang, S., Mallard, K., Joloba, M. L., Mumbowa, F., Narayan, K., … & McNerney, R. (2007). Low-cost rapid detection of rifampicin resistant tuberculosis using bacteriophage in Kampala, Uganda. Annals of Clinical Microbiology and antimicrobials, 6(1), 1-6.

Nabakooza, G., Pastusiak, A., Kateete, D. P., Lutwama, J. J., Kitayimbwa, J. M., & Frost, S. D. W. (2022). Whole-genome analysis to determine the rate and patterns of intra-subtype reassortment among influenza type-A viruses in Africa. Virus Evolution, 8(1), veac005.

Kafeero, H. M., Ndagire, D., Ocama, P., Kato, C. D., Wampande, E., Kajumbula, H., … & Sendagire, H. (2022). Disproportionate distribution of HBV genotypes A and D and the recombinant genotype D/E in the high and low HBV endemic regions of Uganda: A wake-up call for regional specific HBV management. International Journal of Hepatology, 2022.

Najjuka, S. M., Ngabirano, T. D., Balizzakiwa, T., Nabadda, R., Kaggwa, M. M., Kateete, D. P., … & Kiguli, S. (2022). Health care workers perceived self-efficacy to manage COVID-19 patients in central uganda: a cross-sectional study. Risk Management and Healthcare Policy, 1253-1270.

Nakku-Joloba, E., Mboowa, G., Ssengooba, W., Kiyimba, A., Kigozi, E., Baluku, H., … & Kateete, D. P. (2022). Prevalence and antimicrobial resistance profiles of Neisseria gonorrhea and Chlamydia trachomatis isolated from individuals attending STD clinics in Kampala, Uganda. African Health Sciences, 22(3), 62-71.

Galiwango, R., Bainomugisha, E., Kivunike, F., Kateete, D. P., & Jjingo, D. (2022). Air pollution and mobility patterns in two Ugandan cities during COVID-19 mobility restrictions suggest the validity of air quality data as a measure for human mobility. Environmental Science and Pollution Research, 1-16.

Nabakooza, G., Galiwango, R., Frost, S. D., Kateete, D. P., & Kitayimbwa, J. M. (2022). Molecular Epidemiology and Evolutionary Dynamics of Human Influenza Type-A Viruses in Africa: A Systematic Review. Microorganisms, 10(5), 900.

Kwizera, A., Kateete, D. P., Ssenyonga, R., Nakiyingi, L., Nakibuuka, J., Namata, C., … & Summers, C. (2022). Acute respiratory distress syndrome in an African intensive care unit setting: a prospective study of prevalence and outcomes. Annals of the American Thoracic Society, 19(4), 691-694.

Kamulegeya, R., Kateete, D. P., Bagaya, B. S., Nasinghe, E., Muttamba, W., Nsubuga, G., … & Joloba, M. L. (2022). Biobanking: Strengthening Uganda’s Rapid Response to COVID-19 and Other Epidemics. Biopreservation and Biobanking, 20(3), 238-243.

Perier, C., Nasinghe, E., Charles, I., Ssetaba, L. J., Ahyong, V., Bangs, D., … & Schaletzky, J. (2022). Workshop-based learning and networking: a scalable model for research capacity strengthening in low-and middle-income countries. Global Health Action, 15(1), 2062175.

Namaganda, M. M., Sendagire, H., Kateete, D. P., Kigozi, E., Nsubuga, M. L., Katabazi, F. A., … & Mboowa, G. (2022). Next-generation sequencing (NGS) reveals low-abundance HIV-1 drug resistance mutations among patients experiencing virological failure at the time of therapy switching in Uganda. F1000Research, 11(901), 901.

Achan, B., Mboowa, G., Kwizera, R., Kateete, D. P., Kajumbula, H., & Bongomin, F. (2022). Medical Mycology dissertation topics require prioritisation among Postgraduate Microbiology trainees of Makerere University, Uganda. IJID Regions, 3, 261-264.

Ssekagiri, A., Jjingo, D., Lujumba, I., Bbosa, N., Bugembe, D. L., Kateete, D. P., … & Ssemwanga, D. (2022). QuasiFlow: a Nextflow pipeline for analysis of NGS-based HIV-1 drug resistance data. Bioinformatics Advances, 2(1), vbac089.

Masiga, F., Kigozi, E., Najjuka, C. F., Kajumbula, H., & Kateete, D. P. (2022). Diarrhoeagenic Escherichia coli isolated from children with acute diarrhoea at Rakai hospital, Southern Uganda. African Health Sciences, 22(1), 581-8.

Mukasa Kafeero, H., Ndagire, D., Ocama, P., Drago, C. K., Wampande, E., Kajumbula, H., … & Sendagire, H. (2022). TREAT-B Algorithm for Treatment Eligibility Among the Chronically Infected Hepatitis B Virus Persons in a low and a high endemic region: A potential Strategy Towards the Virus Elimination By 2030. Frontiers in virology, 27.

Kafeero, H. M., Ndagire, D., Ocama, P., Kato, C. D., Wampande, E., Walusansa, A., … & Sendagire, H. (2022). Mapping Hepatitis B Virus Genotypes, Recombinant Genotypes and Sub-genotypes on the African continent from 1997 to 2021: A Systematic Review with Meta-Analysis.

Nsubuga, G., Kateete, D. P., Aloyo, S. M., Kigingi, L. N., Emmanuel, N., Dafala, K., … & Rogers, K. (2022). Biobanking in East and Central Africa: A case of the Integrated Biorepository of H3Africa Uganda. Open Research Africa, 5(33), 33.